2015 Financial Highlights
? Revenues: EUR 2.1 million (EUR 0.3 million in 2014).
? Expenses: EUR 14.3 million total cost of sales, distribution costs, administrative
expenses and research & development expenses (EUR 10.5 million in 2014). The
increase was mainly due to the increase in valuation of Phantom Stock Options
? Operating result: EUR 12.1 million (EUR 10.1 million in 2014).
? Net profit / Net loss: EUR 13.8 million (net loss of EUR 12.4 million in 2014). The
difference is mainly due to financial income totaling EUR 25.9 million net, which
primarily resulted from a one-time IFRS accounting entry related to the changes in
fair value measurement of the preferred and common shares of Curetis AG, which
was triggered by the corporate reorganization of the Company.
? Cash & cash equivalents: EUR 46.1 million as of Dec. 31, 2015